As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
North America and Europe are expected to be key markets for giant cell arteritis treatment owing to the high living standards and health awareness among the consumers. The growing health care industry in China and India is driving the market in the Asia Pacific region.
The giant cell arteritis treatment mainly consists of high doses of a corticosteroid drug, such as prednisone. Currently available treatments focus on minimising tissue damage caused by inadequate blood flow. Leading players in the global giant cell arteritis treatment industry, such as Johns Hopkins Hospital, American College of Rheumatology, Duke University Health System, and Lahey Clinic Foundation, Inc., are investing heavily in the research and development activities to develop effective treatments for such autoimmune diseases. Significant technological advancements and the adoption of sonographic assessments are expected to create strong opportunities for market growth.
The approval of orphan drug status to newly developed drugs for the treatment of giant cell arteritis treatment by regulatory authorities like the U.S. Food and Drug Administration (FDA) is also expected to boost the market growth by promoting further drug development through financial incentives and user fee waivers. In September 2020, Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a major biopharmaceutical company, announced that FDA had granted mavrilimumab an Orphan Drug designation to be used in the giant cell arteritis treatment. The company was also expected to announce the data from its phase 2 study of mavrilimumab for the treatment of giant cell arteritis treatment by Q4 2020.
Market Analysis by Type, End Use, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the global giant cell arteritis treatment market include Johns Hopkins Hospital, American College of Rheumatology, Duke University Health System, and Lahey Clinic Foundation, Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.